Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 144 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0.5 mg budesonide effervescent tablet for orodispersible use | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬1. 0.5 mg budesonide effervescent tablet for orodispersible use
| 1件: NR3C1 NR3C1 💬1. 0.5 mg budesonide effervescent tablet for orodispersible use
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬1. 0.5 mg budesonide effervescent tablet for orodispersible use
| ||||||||||||||
| 2 | 1 mg budesonide effervescent tablet for orodispersible use | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬2. 1 mg budesonide effervescent tablet for orodispersible use
| 1件: NR3C1 NR3C1 💬2. 1 mg budesonide effervescent tablet for orodispersible use
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬2. 1 mg budesonide effervescent tablet for orodispersible use
| ||||||||||||||
| 3 | 1mg budesonide effervescent tablet for orodispersible use | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬3. 1mg budesonide effervescent tablet for orodispersible use
| 1件: NR3C1 NR3C1 💬3. 1mg budesonide effervescent tablet for orodispersible use
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬3. 1mg budesonide effervescent tablet for orodispersible use
| ||||||||||||||
| 4 | 2mg budesonide effervescent tablet for orodispersible use | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬4. 2mg budesonide effervescent tablet for orodispersible use
| 1件: NR3C1 NR3C1 💬4. 2mg budesonide effervescent tablet for orodispersible use
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬4. 2mg budesonide effervescent tablet for orodispersible use
| ||||||||||||||
| 5 | 5 mg Montelukast | 1件: Montelukast Montelukast | 1件: Montelukast
Montelukast
💬5. 5 mg Montelukast
| 1件: CYSLTR1 CYSLTR1 💬5. 5 mg Montelukast
| 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬5. 5 mg Montelukast
| ||||||||||||||
| 6 | AK002 | - | - | - | - | 1件: 98 98 💬6. AK002
| ||||||||||||||
| 7 | Allergy immunotherapy (allergy shots) | - | - | - | - | 1件: 98 98 💬7. Allergy immunotherapy (allergy shots)
| ||||||||||||||
| 8 | Alpha-proteinase inhibitor | - | - | - | - | 1件: 98 98 💬8. Alpha-proteinase inhibitor
| ||||||||||||||
| 9 | AMG 157 | 1件: Tezepelumab Tezepelumab | 1件: Tezepelumab
Tezepelumab
💬9. AMG 157
| 1件: TSLP TSLP 💬9. AMG 157
| 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 98 98 💬9. AMG 157
| ||||||||||||||
| 10 | AMG157 | - | - | - | - | 1件: 98 98 💬10. AMG157
|